ArticleHeliyon2023
CerviCell-detector: An object detection approach for identifying the cancerous cells in pap smear images of cervical cancer.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.
- Application of artificial intelligence in cervical cytology: a systematic review of deep learning models, datasets, and reported metrics.Frontiers in big data · 2025Pooled it
- High-Resolution Colony Images of Clinically Isolated Bacteria for Automated Detection and Deep Learning.Scientific data · 2026Article
- High-throughput platform for label-free sorting of 3D spheroids using deep learning.Frontiers in bioengineering and biotechnology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer is the second most commonly seen cancer in women. It affects the cervix portion of the vagina. The most preferred diagnostic test required for screening for cervical cancer is the pap smear test. Pap smear is a time-consuming test as it requires detailed analysis by expert cytologists. Cytologists can screen around 100 to 1000 slides depending upon the availability of advanced equipment. It requires substantial time and effort to carefully examine each slide, identify and classify cells, and make accurate diagnoses. Prolonged periods of visual inspection can increase the likelihood of human errors, such as overlooking abnormalities or misclassifying cells. The sheer volume of slides to be screened can exacerbate fatigue and impact diagnostic accuracy. Due to this reason Artificial intelligence (AI) based computer-aided diagnosis system for the classification and detection of pap smear images is needed. There are some AI-based solutions proposed in the literature, still, an effective and accurate system is under research. In this paper, we implement a state-of-the-art object detection model with a newly available CRIC dataset which follows the Bethesda system for nomenclature. Object detection models implemented are YOLOv5 which uses the CSPNet backbone, Faster R-CNN which has Region Proposal Network (RPN) and Detectron2 framework created by Facebook AI Research (FAIR) Group. ResNext model is implemented among the available models from Detectron2. The CRIC dataset is preprocessed and augmented using Roboflow tool. The performance measures of Average Precision and mean Average precision over the Intersection over Union (IoU) are used to evaluate the effectiveness of the models. The models performed better for two classes namely Normal and Abnormal compared to six classes from the Bethesda system. The highest mean Average Precision (mAP) is observed on the augmented dataset for YOLOv5 models for binary classification with 83 % mAP with IoU in the range of 0.50-0.95.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.